
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602,... ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.43 | -11.2860892388 | 3.81 | 3.97 | 3.29 | 697591 | 3.60801448 | CS |
4 | 1.46 | 76.0416666667 | 1.92 | 3.97 | 1.83 | 918684 | 3.03080088 | CS |
12 | 1.73 | 104.848484848 | 1.65 | 3.97 | 1.05 | 550142 | 2.29568237 | CS |
26 | 1.35 | 66.5024630542 | 2.03 | 3.97 | 1.05 | 555255 | 2.04647961 | CS |
52 | 0.1 | 3.0487804878 | 3.28 | 4.13 | 1.05 | 575249 | 2.50746931 | CS |
156 | -2.46 | -42.1232876712 | 5.84 | 10.88 | 0.359908 | 563596 | 3.01238945 | CS |
260 | -35.91 | -91.3973021125 | 39.29 | 56.5899 | 0.359908 | 429909 | 7.98259011 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions